• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫抑制治疗时代之前,溃疡性结肠炎患者接受强化静脉注射皮质类固醇治疗后的长期结肠切除率。

Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era.

作者信息

Gustavsson Anders, Halfvarson Jonas, Magnuson Anders, Sandberg-Gertzén Hanna, Tysk Curt, Järnerot Gunnar

机构信息

Division of Gastroenterology, Department of Medicine, Orebro University Hospital, Orebro, Sweden.

出版信息

Am J Gastroenterol. 2007 Nov;102(11):2513-9. doi: 10.1111/j.1572-0241.2007.01435.x. Epub 2006 Aug 4.

DOI:10.1111/j.1572-0241.2007.01435.x
PMID:17680849
Abstract

OBJECTIVES

Corticosteroids are a cornerstone in the treatment of a severe attack of ulcerative colitis (UC). The long-term prognosis in this patient group is not well described. We studied the long-term colectomy and relapse rates in patients given intensive intravenous corticosteroid treatment (IIVT) for acute UC.

METHODS

A retrospective clinical study of 158 patients with UC treated in 1975-1982 with IIVT. Patients were followed-up to death, colectomy or last visit.

RESULTS

A total of 11 patients were excluded due to change of diagnosis (N = 10) or lost to follow-up (N = 1). The indication for index IIVT in the remaining 147 patients was a severe attack (N = 61), a moderately severe attack (N = 45), a mild attack (N = 29) or chronic continuous disease (N = 12). The median (range) duration of follow-up was 173 (4-271) months in patients escaping colectomy during the first 3 months. Three months after IIVT, the colectomy rates were 28/61 (46%) in a severe attack, 4/45 (9%) in a moderately severe, and 1/29 (3%) in a mild attack. After 10 yr, the colectomy rates were 39/61 (64%), 22/45 (49%), and 8/29 (28%), respectively. During follow-up, neither colectomy incidence beyond 3 months, time to first relapse nor relapse incidence was influenced by severity of initial attack, except for a lower relapse incidence after a severe attack.

CONCLUSIONS

In patients escaping colectomy during the first 3 months after IIVT, the future prognosis was similar irrespective of initial disease severity.

摘要

目的

皮质类固醇是治疗溃疡性结肠炎(UC)严重发作的基石。该患者群体的长期预后尚无充分描述。我们研究了接受强化静脉注射皮质类固醇治疗(IIVT)的急性UC患者的长期结肠切除术和复发率。

方法

对1975年至1982年接受IIVT治疗的158例UC患者进行回顾性临床研究。对患者进行随访直至死亡、结肠切除术或最后一次就诊。

结果

共有11例患者因诊断改变(n = 10)或失访(n = 1)被排除。其余147例患者首次IIVT的指征为严重发作(n = 61)、中度严重发作(n = 45)、轻度发作(n = 29)或慢性持续疾病(n = 12)。在最初3个月内未接受结肠切除术的患者中,随访的中位(范围)持续时间为173(4 - 271)个月。IIVT后3个月,严重发作患者的结肠切除率为28/61(46%),中度严重发作患者为4/45(9%),轻度发作患者为1/29(3%)。10年后,结肠切除率分别为39/61(64%)、22/45(49%)和8/29(28%)。在随访期间,除严重发作后复发率较低外,3个月后的结肠切除发生率、首次复发时间或复发发生率均不受初始发作严重程度的影响。

结论

在IIVT后最初3个月内未接受结肠切除术的患者中,无论初始疾病严重程度如何,未来预后相似。

相似文献

1
Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era.免疫抑制治疗时代之前,溃疡性结肠炎患者接受强化静脉注射皮质类固醇治疗后的长期结肠切除率。
Am J Gastroenterol. 2007 Nov;102(11):2513-9. doi: 10.1111/j.1572-0241.2007.01435.x. Epub 2006 Aug 4.
2
Colectomy rate in acute severe ulcerative colitis in the infliximab era.英夫利昔单抗时代急性重症溃疡性结肠炎的结肠切除术发生率。
Dig Liver Dis. 2008 Oct;40(10):821-6. doi: 10.1016/j.dld.2008.03.014. Epub 2008 May 9.
3
Short-term efficacy and long-term outcome of cyclosporine treatment in patients with severe ulcerative colitis.环孢素治疗重度溃疡性结肠炎患者的短期疗效及长期预后
Z Gastroenterol. 1998 Apr;36(4):287-93.
4
Outcome of a conservative approach in severe ulcerative colitis.重度溃疡性结肠炎保守治疗的结果
Dig Liver Dis. 2004 Jan;36(1):21-8. doi: 10.1016/j.dld.2003.04.001.
5
Continuous infusion versus bolus administration of steroids in severe attacks of ulcerative colitis: a randomized, double-blind trial.溃疡性结肠炎重度发作时类固醇持续输注与大剂量注射给药的比较:一项随机双盲试验
Am J Gastroenterol. 2007 Mar;102(3):601-8. doi: 10.1111/j.1572-0241.2006.01007.x.
6
A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.口服环丙沙星治疗急性溃疡性结肠炎的前瞻性随机对照试验。
Am J Gastroenterol. 1997 Mar;92(3):454-6.
7
What determines the later clinical course of patients who do not undergo colectomy at the first attack? A Japanese cohort study on ulcerative colitis.哪些因素决定了首次发作时未接受结肠切除术患者的后续临床病程?一项日本溃疡性结肠炎队列研究。
Digestion. 2010;81(2):104-12. doi: 10.1159/000229773.
8
[Frequency and predictive factors of colectomy and restorative colo-proctectomy in ulcerative colitis].[溃疡性结肠炎患者结肠切除术和结直肠重建性切除术的频率及预测因素]
Tunis Med. 2009 Feb;87(2):115-9.
9
Response to first intravenous steroid therapy determines the subsequent risk of colectomy in ulcerative colitis patients.对于溃疡性结肠炎患者,首次静脉用类固醇治疗的反应决定了随后结肠切除术的风险。
J Gastrointestin Liver Dis. 2011 Dec;20(4):359-63.
10
Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis.环孢素诱导重症溃疡性结肠炎缓解后的长期随访期间结肠切除术的发生率。
Clin Gastroenterol Hepatol. 2006 Jun;4(6):760-5. doi: 10.1016/j.cgh.2006.04.001. Epub 2006 May 22.

引用本文的文献

1
A Retrospective Observational Study of Patterns of Biologic Drug Change in Inflammatory Bowel Disease.炎症性肠病生物药物变化模式的回顾性观察研究
Inflamm Intest Dis. 2024 Mar 12;9(1):71-84. doi: 10.1159/000538250. eCollection 2024 Jan-Dec.
2
Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis.真实世界疗效和安全性监测预测溃疡性结肠炎患者托法替布治疗的持续。
Dig Dis Sci. 2022 Aug;67(8):3984-3992. doi: 10.1007/s10620-021-07233-6. Epub 2021 Aug 30.
3
Maintaining infliximab induced clinical remission with azathioprine and 5-aminosalicylates in acute severe steroid-refractory ulcerative colitis has lower cost and high efficacy (MIRACLE): a multicenter study.
硫唑嘌呤和5-氨基水杨酸维持英夫利昔单抗诱导的急性重症激素难治性溃疡性结肠炎临床缓解的成本较低且疗效高(MIRACLE):一项多中心研究
Intest Res. 2022 Jan;20(1):64-71. doi: 10.5217/ir.2020.00100. Epub 2021 Feb 3.
4
Long-term outcomes of acute severe ulcerative colitis in the rescue therapy era: A multicentre cohort study.急性重症溃疡性结肠炎在挽救治疗时代的长期结局:一项多中心队列研究。
United European Gastroenterol J. 2021 May;9(4):507-516. doi: 10.1177/2050640620977405. Epub 2021 Feb 16.
5
Flightless I exacerbation of inflammatory responses contributes to increased colonic damage in a mouse model of dextran sulphate sodium-induced ulcerative colitis.无飞行能力会加剧炎症反应,导致葡聚糖硫酸钠诱导的溃疡性结肠炎小鼠模型中结肠损伤增加。
Sci Rep. 2019 Sep 5;9(1):12792. doi: 10.1038/s41598-019-49129-6.
6
Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.他克莫司在住院的类固醇难治性急性重度溃疡性结肠炎患者中的疗效。
World J Gastroenterol. 2019 Apr 7;25(13):1603-1617. doi: 10.3748/wjg.v25.i13.1603.
7
Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.中重度炎症性肠病的常规治疗:系统文献回顾。
World J Gastroenterol. 2019 Mar 7;25(9):1142-1157. doi: 10.3748/wjg.v25.i9.1142.
8
Pooled analysis of the comparative efficacy between tacrolimus and infliximab for ulcerative colitis.他克莫司与英夫利昔单抗治疗溃疡性结肠炎的疗效比较的汇总分析。
Medicine (Baltimore). 2018 Aug;97(32):e11440. doi: 10.1097/MD.0000000000011440.
9
Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East.印度炎症性肠病的流行病学:向东方的重大转变。
Inflamm Intest Dis. 2017 Nov;2(2):102-115. doi: 10.1159/000465522. Epub 2017 Apr 8.
10
Urolithiasis and crohn's disease.尿石症与克罗恩病
Urol Ann. 2016 Jul-Sep;8(3):297-304. doi: 10.4103/0974-7796.184879.